References
Confalonieri M, Urbino R, Potena A et al (2005) Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171:242–248
Garcia-Vidal C, Calbo E, Pascual V et al (2007) Effects of systemic steroids in patients with severe community-acquired pneumonia. Eur Respir J 30:951–956
Nie W, Zhang Y, Cheng J, Xiu Q (2012) Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis. PLoS One 7:e47926
Torres A, Sibila O, Ferrer M et al (2015) Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA 313:677–686
Tagami T, Matsui H, Horiguchi H et al (2015) Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients. Eur Respir J 45:463–472
Siemieniuk RA, Meade MO, Alonso-Coello P et al (2015) Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis. Ann Intern Med 163:519–528
Marti C, Grosgurin O, Harbarth S et al (2015) Adjunctive corticotherapy for community acquired pneumonia: a systematic review and meta-analysis. PLoS One 10:e0144032
Horita N, Otsuka T, Haranaga S et al (2015) Adjunctive systemic corticosteroids for hospitalized community-acquired pneumonia: systematic review and meta-analysis 2015 update. Sci Rep 5:14061
Chen LP, Chen JH, Chen Y et al (2015) Efficacy and safety of glucocorticoids in the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials. World J Emerg Med 6:172–178
Wan YD, Sun TW, Liu ZQ et al (2016) Efficacy and safety of corticosteroids for community-acquired pneumonia: a systematic review and meta-analysis. Chest 149:209–219
Briel M, Spoorenberg SMC, Snijders D et al (2017) Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data meta-analysis. Clin Infect Dis. https://doi.org/10.1093/cid/cix801
Pastores SM, Annane D, Rochwerg B, The Corticosteroid Guideline Task Force of SCCM and ESICM (2017) Guidelines for the diagnosis of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. https://doi.org/10.1007/s00134-017-4951-5
Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS (2016) Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858
Cooley L, Dendle C, Wolf J et al (2014) Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies. Intern Med J 44(12b):1350–1363
Lemiale V, Debrumetz A, Delannoy et al (2013) Adjunctive steroid in HIV-negative patients with severe Pneumocystis pneumonia. Respir Res 14:87
Hoffman SL, Punjabi NH, Kumala S et al (1984) Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. N Engl J Med 310(2):82–88
Rogerson SJ, Spooner VJ, Smith TA, Richens J (1991) Hydrocortisone in chloramphenicol-treated severe typhoid fever in Papua New Guinea. Trans R Soc Trop Med Hyg 85:113–116
Brouwer MC, McIntyre P, Prasad K, van de Beek D (2015) Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.cd004405.pub5
van de Beek D, Cabellos C, Dzupova O et al (2016) ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect 22(Suppl 3):S37–S62
de Gans J, van de Beek D, European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators (2002) Dexamethasone in adults with bacterial meningitis. N Engl J Med 347(20):1549–1556
Prasad K, Singh MB, Ryan H (2016) Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.cd002244.pub4
Wiysonge CS, Ntsekhe M, Thabane L et al (2017) Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.cd000526.pub2
Ryan H, Yoo J, Darsini P (2017) Corticosteroids for tuberculous pleurisy. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.cd001876.pub3
Sharma SK, Mohan A, Sharma A, Mitra DK (2005) Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis 5(7):415–430
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
José Manuel Pereira: received honoraria for lectures from MSD, Astellas, Pfizer and Novartis. Thiago Lisboa: no conflicts of interest. José Artur Paiva: no conflicts of interest.
Rights and permissions
About this article
Cite this article
Pereira, J.M., Lisboa, T. & Paiva, JA. Adjuvant therapies in critical care: steroids to treat infectious diseases. Intensive Care Med 44, 1306–1309 (2018). https://doi.org/10.1007/s00134-017-5020-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-017-5020-9